Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

Alan Knight delivered an encouraging update on his ongoing cancer battle and insisted: I feel okay. In September, the Blues ...

Risk factors for osteoporosis, with Jim Squires revealing his shock diagnosis aged 27 after taking steroids for arthritis and ...

As our TV columnist recovers from cancer operations, she focuses on two new limited series about women who claimed to have ...

Aurora Pharmaceutical is pleased to announce the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

VAIL, CO USA (UroToday.com) - Background: Two oral agents have recently been approved for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC): abiraterone acetate ...

Low T levels cause muscle loss and constant fatigue as you age, and the best te͏stosterone b͏oosters, like TestoPrime and D-Bal Max, may just ...

The FDA has approved FoundationOne CDx and FoundationOne Liquid CDx as companion diagnostics to be used with olaparib, abiraterone, and prednisone or prednisolone BRCA-mutated metastatic ...

Qian Qin presented the HARMONY trial, a phase II study evaluating the combination of niraparib, abiraterone acetate, and prednisone in Hispanic/Latino and non-Hispanic Black patients with metastatic ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.